Clinical Trials Browser

Unknown × SHR-1210 × camrelizumab × Clear all

NCT04797507 2021-03-15

SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell Cancer

Phase 2 Unknown

Gastrointestinal

SHR-1210